Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anthony R. Gangloff is active.

Publication


Featured researches published by Anthony R. Gangloff.


Tetrahedron Letters | 2001

Synthesis of 3,5-disubstituted-1,2,4-oxadiazoles using tetrabutylammonium fluoride as a mild and efficient catalyst

Anthony R. Gangloff; Joane Litvak; Emma J. Shelton; David Sperandio; Vivian R. Wang; Kenneth D. Rice

Tetrabutylammonium fluoride (TBAF) was found to be a mild and efficient catalyst for the synthesis of 3,5-disubstituted-1,2,4-oxadiazoles. Using 0.1–1.0 equivalents of TBAF in THF for 1–24 h at room temperature, alkanoyl- and aroyloxyamidines were converted in high yield to the corresponding 3,5-disubstituted-1,2,4-oxadiazoles. A variety of R and R′ substituents were investigated.


Tetrahedron | 1993

Rhodium-catalyzed heterocycloaddition route to 1,3-oxazoles as building blocks in natural products synthesis

Richard D. Connell; Mark Tebbe; Anthony R. Gangloff; Paul Helquist; Björn Åkermark

Abstract Rhodium(II) acetate serves as a catalyst for the heterocycloaddition reaction of diazodicarbonyl compounds with nitriles to give functionalized 1,3-oxazole derivatives in a simple one-step procedure. In particular, dimethyl diazomalonate undergoes this reaction to give 2-aryl-, 2-alkenyl-, or 2-alkyl-4-carbomethoxy-5-methoxy-1,3-oxazoles, and ethyl formyldiazoacetate (diazomalonate half-ester half-aldehyde) gives 2-aryl-, 2-alkenyl-, or 2-alkyl-4-carboethoxy-1,3-oxazoles. These products are of potential importance as key intermediates in the synthesis of several oxazole-containing natural products and other heterocyclic systems.


Tetrahedron Letters | 1993

Synthesis of the oxazole- and diene-containing C9–C23 fragment of the type a streptogramin antibiotics

Mikael Bergdahl; Robert Hett; Timothy L. Friebe; Anthony R. Gangloff; Javed Iqbal; Yinghui Wu; Paul Helquist

Abstract The right-hand portion (3) of the type A streptogramin antibiotics was synthesized in non-racemic form through use of a Horner-Wadsworth-Emmons reaction for diene construction, an asymmetric aldol condensation, and a zinc-promoted oxazole addition reaction.


Pure and Applied Chemistry | 1994

Synthesis of macrocyclic lactam/lactone derivatives having antimicrobial activity

Paul Helquist; Mikael Bergdahl; Robert Hett; Anthony R. Gangloff; Marc Demillequand; Muriel Cottard; M. M. Mader; Timothy L. Friebe; J. Iqbal; Y. Wu; Björn Akermark; T. Rein; Nina Kann

A number of new synthetic methods have been developed that are applicable to several types of antibiotics possessing macrocyclic lactone or lactam structures. These methods have permitted the synthe- sis of several key subunits of these compounds, and progress has been made on the total synthesis of some of these antibiotics. The type A streptogramin antibiotics have served as a special focus of these efforts. In addition, a combination of microbiological and chemical methods have been investigated for the direct modification of the naturally occurring antibiotics. Included among macrocyclic compounds of current biomedical interest are the streptogramin antibi- otics (l), the trienomycins (2), and the iejimalides (3). These compounds occur naturally as highly func- tionalized macrocyclic lactam or lactone systems. Madumycin I c1> is a representative member of the type A streptogramin series which comprises several antibiotics having wide-ranging applications. The trieno- mycins (2) and the iejimalides a show potent cytotoxicity in a variety of assays. The rich structural diversity of these compounds and their important biological activity has prompted us to use them as platforms for the development of new synthetic methods that may ultimately be applied to the total synthesis of these compounds and various analogues for further biomedical investigations. Con- siderable progress has been made in these efforts. In this brief paper, our results will be exemplified by our most recent progress on the synthesis of the streptogramin antibiotics. A more comprehensive description of our earlier work in this area has been published previously (4). Our basic strategy for the synthesis of the streptogramin antibiotics is shown for madumycin (Fig. 1). A number of new methods have been developed for the synthesis of the individual subunits shown in this strategy. Considerable attention was initially devoted to the types of functionalized 1,3-dienes and polyenes seen in 1 - 2, and a number of methods were investigated, especially through use of various pal- ladium-catalyzed reactions and new phosphonate reagents (5). Stereoselective routes were developed for the unsaturated acid subunit seen on the left of Fig. 1 through use of asymmetric aldol condensations and other approaches (6). A rhodium-catalyzed reaction of diazocarbonyl compounds with nitriles was devel- oped for the synthesis of 4-carboxy-1,3-oxazole derivatives as seen in all of the type A streptogramin antibiotics (7). Titanium- and zirconium-catalyzed lactamization reactions were also investigated which


Bioorganic & Medicinal Chemistry Letters | 2001

Monocharged inhibitors of mast cell tryptase derived from potent and selective dibasic inhibitors

Jeffrey Mark Dener; Vivian R. Wang; Kenneth D. Rice; Anthony R. Gangloff; Elaine Y.-L Kuo; William S Newcomb; Daun Putnam; Martin Wong

Truncation of potent and selective dibasic inhibitors afforded monocharged inhibitors of human mast-cell tryptase. Using two classes of analogues as lead structures, several monocharged derivatives were identified with K(i) values ranging from 0.084 to 0.21 microM against the enzyme.


Archive | 1995

Compositions and methods for treating mast-cell mediated conditions

Ken Rice; Jeffrey Mark Dener; Anthony R. Gangloff; Elaine Yee-Lin Kuo


Journal of Organic Chemistry | 1992

Generation and use of a zinc derivative of a functionalized 1,3-oxazole. Solution of the virginiamycin/madumycin oxazole problem

Anthony R. Gangloff; Bjoern Aakermark; Paul Helquist


Archive | 1995

Compositions and methods for treating mast-cell inflammatory condition

Ken Rice; Jeffrey Mark Dener; Anthony R. Gangloff; Elaine Yee-Lin Kuo


Archive | 2003

3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis

Anthony R. Gangloff; Joane Litvak; Keith Pararajasingham; David Sperandio


Archive | 2000

Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity

Timothy J. Church; Neil Scott Cutshall; Anthony R. Gangloff; Thomas E. Jenkins; Martin S. Linsell; Joane Litvak; Kenneth D. Rice; Jeffrey R. Spencer; Vivian R. Wang

Collaboration


Dive into the Anthony R. Gangloff's collaboration.

Top Co-Authors

Avatar

Paul Helquist

University of Notre Dame

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Vivian R. Wang

California State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jeffrey R. Spencer

California Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge